What is the history of Cherubism?

Cherubism was first described in 1933 by Dr. William Jones, who coined the term to reflect the "cherubic" or angelic appearance of affected children due to bilateral jaw swelling. Since its discovery, our understanding of Cherubism has evolved from a mysterious bone condition to a well-defined genetic disorder caused by mutations in the SH3BP2 gene.

Who first discovered Cherubism?

In 1933, the physician William Jones identified three siblings in a single family who exhibited painless, progressive enlargement of the lower face. He famously named the condition Cherubism because the children’s rounded, upturned eyes and full cheeks were reminiscent of the cherubs depicted in Renaissance paintings. Initially, early researchers struggled to distinguish Cherubism from other giant-cell lesions of the bone, leading to historical confusion regarding its classification.

How has our understanding of Cherubism evolved?

For decades, clinicians viewed Cherubism as a localized bone tumor, often leading to overly aggressive surgical interventions that resulted in facial deformities. The landscape changed dramatically in 2001, when researchers identified the SH3BP2 gene mutation as the primary cause. This genetic breakthrough confirmed that Cherubism is an autosomal dominant condition, meaning a child has a 50% chance of inheriting the mutation if one parent is affected.

What are the major milestones in managing the condition?

Medical management has shifted from historical surgical excision to a more conservative, observation-based approach. Key milestones include:

• 1933: Initial clinical description by Dr. William Jones.


• 2001: Identification of the SH3BP2 mutation, enabling accurate genetic counseling.


• Current Era: Focus on "watchful waiting," as the fibro-osseous lesions in Cherubism often regress or stabilize spontaneously after puberty.


• Technological Advancements: Use of 3D imaging and cone-beam CT scans to monitor bone remodeling without excessive radiation.

How has patient advocacy changed the landscape?

Historically, the rarity of Cherubism led to significant social isolation for patients. Today, organizations like DiseaseMaps.org provide a platform for the global community to connect. By sharing personal experiences, patients with Cherubism are helping researchers document the natural history of the disease, moving the focus toward psychosocial support and quality-of-life outcomes.

Next steps

• Consult with a craniofacial surgeon or an oral and maxillofacial pathologist for specialized care.


• Seek genetic counseling to understand the inheritance pattern of Cherubism for family planning.


• Join communities like DiseaseMaps.org to connect with others who have navigated this diagnosis.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cherubism overview.


• OMIM (Online Mendelian Inheritance in Man): Entry #118400 (Cherubism).


• Orphanet: Rare disease database entry for Cherubism (ORPHA:167).


• PubMed: Landmark 2001 study on SH3BP2 mutations in patients with Cherubism.